Biopsy Devices Market Size, Share, and Trends 2025 to 2034

The global biopsy devices market is projected to grow from USD 2.63 billion in 2025 to approximately USD 4.89 billion by 2034, at a CAGR of 7.16%. Needle-based biopsy guns led the product segment, while biopsy needles are expected to grow at a CAGR of 8.6%. Hospitals accounted for the largest end-use share, with clinics projected to expand at the fastest rate during the forecast period.

Last Updated : June 2025  |  Report Code : 3612  |  Category : Healthcare  |  Format : PDF / PPT / Excel

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Biopsy Devices Market 

5.1. COVID-19 Landscape: Biopsy Devices Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Biopsy Devices Market, By Application

8.1. Biopsy Devices Market Revenue and Volume, by Application

8.1.1. Needle-based Biopsy Guns

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Biopsy Guidance Systems

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Biopsy Forceps

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Biopsy Needles

8.1.4.1. Market Revenue and Volume Forecast

Chapter 9. Global Biopsy Devices Market, By End Use

9.1. Biopsy Devices Market Revenue and Volume, by End Use

9.1.1. Hospitals

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Clinics

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Others

9.1.3.1. Market Revenue and Volume Forecast

Chapter 10. Global Biopsy Devices Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Volume Forecast, by Application

10.1.2. Market Revenue and Volume Forecast, by End Use

10.1.3. U.S.

10.1.3.1. Market Revenue and Volume Forecast, by Application

10.1.3.2. Market Revenue and Volume Forecast, by End Use

10.1.4. Rest of North America

10.1.4.1. Market Revenue and Volume Forecast, by Application

10.1.4.2. Market Revenue and Volume Forecast, by End Use

10.2. Europe

10.2.1. Market Revenue and Volume Forecast, by Application

10.2.2. Market Revenue and Volume Forecast, by End Use

10.2.3. UK

10.2.3.1. Market Revenue and Volume Forecast, by Application

10.2.3.2. Market Revenue and Volume Forecast, by End Use

10.2.4. Germany

10.2.4.1. Market Revenue and Volume Forecast, by Application

10.2.4.2. Market Revenue and Volume Forecast, by End Use

10.2.5. France

10.2.5.1. Market Revenue and Volume Forecast, by Application

10.2.5.2. Market Revenue and Volume Forecast, by End Use

10.2.6. Rest of Europe

10.2.6.1. Market Revenue and Volume Forecast, by Application

10.2.6.2. Market Revenue and Volume Forecast, by End Use

10.3. APAC

10.3.1. Market Revenue and Volume Forecast, by Application

10.3.2. Market Revenue and Volume Forecast, by End Use

10.3.3. India

10.3.3.1. Market Revenue and Volume Forecast, by Application

10.3.3.2. Market Revenue and Volume Forecast, by End Use

10.3.4. China

10.3.4.1. Market Revenue and Volume Forecast, by Application

10.3.4.2. Market Revenue and Volume Forecast, by End Use

10.3.5. Japan

10.3.5.1. Market Revenue and Volume Forecast, by Application

10.3.5.2. Market Revenue and Volume Forecast, by End Use

10.3.6. Rest of APAC

10.3.6.1. Market Revenue and Volume Forecast, by Application

10.3.6.2. Market Revenue and Volume Forecast, by End Use

10.4. MEA

10.4.1. Market Revenue and Volume Forecast, by Application

10.4.2. Market Revenue and Volume Forecast, by End Use

10.4.3. GCC

10.4.3.1. Market Revenue and Volume Forecast, by Application

10.4.3.2. Market Revenue and Volume Forecast, by End Use

10.4.4. North Africa

10.4.4.1. Market Revenue and Volume Forecast, by Application

10.4.4.2. Market Revenue and Volume Forecast, by End Use

10.4.5. South Africa

10.4.5.1. Market Revenue and Volume Forecast, by Application

10.4.5.2. Market Revenue and Volume Forecast, by End Use

10.4.6. Rest of MEA

10.4.6.1. Market Revenue and Volume Forecast, by Application

10.4.6.2. Market Revenue and Volume Forecast, by End Use

10.5. Latin America

10.5.1. Market Revenue and Volume Forecast, by Application

10.5.2. Market Revenue and Volume Forecast, by End Use

10.5.3. Brazil

10.5.3.1. Market Revenue and Volume Forecast, by Application

10.5.3.2. Market Revenue and Volume Forecast, by End Use

10.5.4. Rest of LATAM

10.5.4.1. Market Revenue and Volume Forecast, by Application

10.5.4.2. Market Revenue and Volume Forecast, by End Use

Chapter 11. Company Profiles

11.1. Medtronic plc

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Becton, Dickinson, and Company

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. Hologic, Inc.

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Boston Scientific Corporation

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. Olympus Corporation

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. C. R. Bard, Inc. (acquired by BD)

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Cook Medical LLC

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. FUJIFILM Holdings Corporation

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. Mauna Kea Technologies

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. Devicor Medical Products, Inc.

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global biopsy devices market size is expected to increase USD 4.89 billion by 2034 from USD 2.45 billion in 2024.

The global biopsy devices market will register growth rate of 7.16% between 2025 to 2034.

The major players operating in the biopsy devices market are Medtronic plc, Becton, Dickinson and Company, Hologic, Inc., Boston Scientific Corporation, Olympus Corporation, C. R. Bard, Inc. (acquired by BD), Cook Medical LLC, FUJIFILM Holdings Corporation, Mauna Kea Technologies, Devicor Medical Products, Inc., Leica Biosystems Nussloch GmbH (Danaher Corporation), INRAD Inc., Argon Medical Devices, Inc. (acquired by Shandong Weigao Group Medical Polymer Company Limited), and Others.

The driving factors of the biopsy devices market are the growing technological advancements and increasing disease burden.

North America region will lead the global biopsy devices market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client